Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament

DSpace/Manakin Repository

Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author McPhie, David C. en_US
dc.date.accessioned 2012-06-07T20:08:14Z
dc.date.issued 2003 en_US
dc.identifier.citation Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament (2003 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852107
dc.description.abstract In early 2003, two panels of the Federal Circuit clashed in a pair of cases (Warner-Lambert v. Apotex and Allergan v. Alcon) dealing with the question of whether an action for inducement of infringement could be leveled against a generic drug manufacturer seeking FDA approval for an unpatented drug with both patented and unpatented uses. This paper takes up this debate, analyzing the interpretive puzzles presented in the application of the intricate Hatch-Waxman Act to this set of facts, arguing that the correct interpretation weaves elements from both panels’ approaches. It finishes with an alternative solution borrowed from a lesson in copyright. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject Hatch-Waxman en
dc.title Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T20:08:14Z

Files in this item

Files Size Format View
McPhie.pdf 176.7Kb PDF View/Open
McPhie.rtf 103.1Kb RTF file View/Open
McPhie.html 83.28Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters